Clinical Trials Directory

Trials / Unknown

UnknownNCT01985152

A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers

A Placebo-Controlled, Phase I, Single-center Evaluation of the Single-dose Pharmacokinetics Study of Azilsartan Trimethylethanolamine

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the Pharmacokinetics and safety of Azilsartan Trimethylethanolamine in healthy volunteers

Conditions

Interventions

TypeNameDescription
DRUGAzilsartan Trimethylethanolamine
DRUGPlacebo

Timeline

Start date
2013-09-01
Primary completion
2013-12-01
First posted
2013-11-15
Last updated
2013-11-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01985152. Inclusion in this directory is not an endorsement.